Cryoablative response of prostate cancer cells is influenced by androgen receptor expression

BJU International

Volumn 101, Issue 10, 2008, Pages 1310-1316

  Klossner, Daniel P ^a,b   Baust, John M ^a,b   VanBuskirk, Robert G ^a,b   Gage, Andrew A ^b,c   Baust, John G ^a,d  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b Cell Preservation Services Inc   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

^d BINGHAMTON UNIVERSITY   (United States)

Author keywords

Androgen sensitivity; Apoptosis; Caspase; Cryosurgery; Prostate cancer

Indexed keywords

ANDROGEN RECEPTOR; CASPASE INHIBITOR; FLUORESCENT DYE;

ANDROGEN INSENSITIVITY SYNDROME; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER THERAPY; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CRYOABLATION; ENZYME ACTIVITY; ENZYME INHIBITION; FREEZING; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSFECTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; LOW TEMPERATURE; MALE; MOLECULAR PROBE; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CRYOSURGERY; HUMANS; MALE; NEOPLASMS, HORMONE-DEPENDENT; PHENOTYPE; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 42249095056     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.07499.x     Document Type: Article

References (24)

1. Jemal A, Siegel R, Ward E et al. Cancer statistics. CA Cancer J Clin 2006 56 : 106 30
2. Powell SM, Brooke GN, Whitaker HC et al. Mechanisms of androgen receptor repression in prostate cancer. Biochem Soc Trans 2006 34 : 1124 7
3. Kish JA, Bukkapatnam R, Palazzo F. The treatment challenge of hormone-refractory prostate cancer. Cancer Control 2001 8 : 487 95
4. Hellerstedt BA, Pienta KJ. The current state of hormonal therapy for prostate cancer. CA Cancer J Clin 2002 52 : 154 79
5. Bhandari MS, Petrylak DP, Hussain M. Clinical trials in metastatic prostate cancer - has there been real progress in the past decade? Eur J Cancer 2005 41 : 941 53
6. Bahn DK, Lee FB, Salament R, Kumar A, Greski J, Chernick M. Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer. Urology 2002 60 (Suppl. 2A 3 11
7. Bahn DK, Lee F, Silverman P et al. Salvage cryosurgery for recurrent prostate cancer after radiation therapy: a seven-year follow-up. Clin Prostate Cancer 2003 2 : 111 4
8. Chatterjee B. The role of the androgen receptor in the development of prostatic hyperplasia and prostate cancer. Mol Cell Biochem 2003 253 : 89 101
9. Navarro D, Luzardo OP, Fernandez L, Chesa N, Diaz-Chico BN. Transition to androgen-independence in prostate cancer. J Steroid Biochem Mol Biol 2002 81 : 191 201
10. Sanchez D, Rosell D, Honorato BZ, Lopez J, Arocena J, Sanz G. Androgen receptor mutations are associated with Gleason score in localized prostate cancer. BJU Int 2006 98 : 1320 5
11. Hendriksen PJ, Dits NF, Kokame K et al. Evolution of the androgen receptor pathway during progression of prostate cancer. Cancer Res 2006 66 : 5012 20
12. Baust JG, Gage AA, Clarke D, Baust JM, Van Buskirk R. Cryosurgery - a putative approach to molecular-based optimization. Cryobiology 2004 48 : 190 204
13. Mouraviev V, Polascik TJ. Update on cryotherapy for prostate cancer in 2006. Curr Opin Urol 2006 16 : 152 6
14. Baust JG, Gage AA, Klossner DP et al. Issues critical to the successful application of cryosurgical ablation of the prostate. Technol Cancer Res Treat 2007 6 : 97 109
15. Katz AE, Rukstalis DB. Introduction. Recent scientific and technological advances have challenged the traditional treatment options for patients with localized prostate cancer. Urology 2002 60 (Suppl. 2A 1 2
16. Gage AA, Baust JG. Cryosurgery for tumors - a clinical overview. Technol Cancer Res Treat 2004 3 : 187 99
17. Baust JG, Gage AA. The molecular basis of cryosurgery. BJU Int 2005 95 : 1187 91
18. Hollister WR, Mathew AJ, Baust JG, Van Buskirk RG. Effects of freezing on cell viability and mechanisms of cell death in a human prostate cell line. Mol Urol 1998 2 : 3 18
19. Clarke DM, Baust JM, Van Buskirk RG, Baust JG. Chemo-cryo combination therapy: an adjunctive model for the treatment of prostate cancer. Cryobiology 2001 42 : 274 85
20. Clarke DM, Robilotto AT, Van Buskirk RG, Baust JG, Gage AA, Baust JM. Targeted induction of apoptosis via TRAIL and cryoablation: a novel strategy for the treatment of prostate cancer. Prostate Cancer and Prostatic Dis 2007 10 : 175 84
21. Le Pivert P, Haddad RS, Aller A et al. Ultrasound guided combined cryoablation and microencapsulated 5-Fluorouracil inhibits growth of human prostate tumors in xenogenic mouse model assessed by luminescence imaging. Technol Cancer Res Treat 2004 3 : 135 42
22. Berger R, Febbo PG, Majumder PK et al. Androgen-induced differentiation and tumorigenicity of human prostate epithelial cells. Cancer Res 2004 64 : 8867 75
23. Onik G. Image-guided prostate cryosurgery: state of the art. Cancer Control 2001 8 : 522 31
24. Lin Y, Kokontis J, Tang F et al. Androgen and its receptor promote Bax-mediated apoptosis. Mol Cell Biol 2006 26 : 1908 16